HCMV strain- or glycoprotein complex-specific neutralizing antibodies modulate HCMV infection by preventing binding of HCMV to target cells (Martins et al., 2019; Shibamura et al., 2020). This evidence concerns the gene ART4 and cytomegalovirus infection.